Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Recruiting now · Phase 3
Conditions studied: Locally Advanced (Inoperable) or Metastatic Breast Cancer
In brief
A Phase Ib/III Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6 Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced, Unresectable or Metastatic Breast Cancer (CAPItello-292)
Key facts
- Study ID
- NCT04862663
- Run by
- AstraZeneca
- People needed
- 895
- Starts
- 2021-05-10
- Expected to finish
- 2029-08-14
- Last updated by the study team
- 2026-06-29
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Pittsburgh, Pennsylvania, United States (enrolling)
- Research Site — Nashville, Tennessee, United States (enrolling)
- Research Site — Omaha, Nebraska, United States (enrolling)
- Research Site — Gresham, Oregon, United States (enrolling)
- Research Site — Napa, California, United States (enrolling)
- Research Site — Chattanooga, Tennessee, United States (enrolling)
- Research Site — Tucson, Arizona, United States (enrolling)
- Research Site — St Louis, Missouri, United States (enrolling)
- Research Site — Fountain Valley, California, United States (enrolling)
- Research Site — New York, New York, United States (enrolling)
- Research Site — New Haven, Connecticut, United States (enrolling)
- Research Site — Newark, Delaware, United States (enrolling)
- Research Site — Newport Beach, California, United States (enrolling)
- Research Site — Glendale, California, United States (enrolling)
- Research Site — San Francisco, California, United States (enrolling)
- Research Site — Louisville, Kentucky, United States (enrolling)
- Research Site — Los Angeles, California, United States (enrolling)
- Research Site — Hannibal, Missouri, United States (enrolling)
- Research Site — Annapolis, Maryland, United States (enrolling)
- Research Site — Santa Rosa, California, United States (enrolling)
- Research Site — Aurora, Colorado, United States (enrolling)
- Research Site — Camden, New Jersey, United States (enrolling)
- Research Site — Detroit, Michigan, United States (enrolling)
- Research Site — Grand Rapids, Michigan, United States (enrolling)
- Research Site — Dallas, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.